Greg Gianforte sold GlaxoSmithKline PLC ADR (NYSE: GSK)
Greg Gianforte (R-MT), a U.S. Representative, has disclosed 4 trades in GlaxoSmithKline PLC ADR (GSK) since 2017, 2 purchases and 2 sales, worth an estimated $191K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Greg Gianforte sold $50,001 - $100,000 of GlaxoSmithKline PLC ADR (NYSE: GSK) on December 14, 2017. Since that trade, GSK is up +123.31% against the S&P 500 up +213.57%, an outperformance of -90.26%.
Across these filings, Greg Gianforte has been a balanced trader of GSK (a buy-to-sell ratio of 1.00). The most recent disclosed GSK transaction shown was dated March 18, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Greg Gianforte's GSK trades vs the price
GSK is up +123.31% since Greg Gianforte sold on December 14, 2017, versus +213.57% for the S&P 500.
Performance since this trade
All Greg Gianforte GSK trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| March 18, 2020 | BUY | $26.09 | +103.95% | +$20K | |
| December 21, 2018 | SELL | $26.85 | +98.25% | — | |
| March 26, 2018 | BUY | $25.76 | +106.64% | +$1K | |
| December 14, 2017 | SELL | $23.83 | +123.31% | — |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Greg Gianforte & GSK trading FAQ
Is it legal for Greg Gianforte to trade GlaxoSmithKline PLC ADR (GSK) stock?
Yes. Members of Congress are allowed to trade individual stocks, including GlaxoSmithKline PLC ADR (GSK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Greg Gianforte sell GSK?
Greg Gianforte disclosed a sale of $50,001 - $100,000 of GlaxoSmithKline PLC ADR (GSK) on December 14, 2017, according to public STOCK Act filings.
How has GSK performed since Greg Gianforte's trade?
Since Greg Gianforte sold GSK on December 14, 2017, the stock is up +123.31%, versus +213.57% for the S&P 500 over the same period, an outperformance of -90.26%.
How many times has Greg Gianforte traded GSK?
Greg Gianforte has disclosed 4 GSK trades since 2017 (2 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GSK trades?
Quantellect tracks every disclosed congressional trade in GlaxoSmithKline PLC ADR (GSK) on the GlaxoSmithKline PLC ADR congressional trading page, which aggregates filings across all members of Congress.
Greg Gianforte's GSK tradesAll congressional filings for GlaxoSmithKline PLC ADRGreg Gianforte's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.